1. Pituitary apoplexy manifested during a bromocriptine test in a patient with a growth hormone- and prolactin-producing pituitary adenoma.
- Author
-
Shirataki K, Chihara K, Shibata Y, Tamaki N, Matsumoto S, and Fujita T
- Subjects
- Adenoma surgery, Female, Humans, Middle Aged, Pituitary Apoplexy complications, Pituitary Apoplexy physiopathology, Pituitary Neoplasms surgery, Vision Disorders complications, Vision Disorders physiopathology, Adenoma complications, Bromocriptine adverse effects, Pituitary Apoplexy chemically induced, Pituitary Neoplasms complications, Vision Disorders chemically induced
- Abstract
This report describes the clinical course of pituitary apoplexy induced by a single dose of bromocriptine in a 50-year-old woman with acromegaly. The patient suddenly complained of diminished vision and headache 2 hours after the oral administration of 2.5 mg of bromocriptine. Her visual symptoms and headache persisted for several days. The basal plasma GH concentration decreased from 76.2 ng/ml to 37.2 ng/ml the day after the attack of apoplexy and to 3.0 ng/ml on the 9th day. The authors assess the changes in endocrine findings related to pituitary apoplexy and also emphasize the necessity to view with caution any symptomatic change during bromocriptine therapy.
- Published
- 1988
- Full Text
- View/download PDF